![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Caption: John Quackenbush, Ph.D., and colleagues have identified a subtype of ovarian cancer able to build its own blood vessels, suggesting that such tumors might be especially susceptible to anti-angiogenic drugs that block blood vessel formation.
Credit: Sam Ogden
Usage Restrictions: None
Related news release: New subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs
|